Novavax COVID Shot, Aimed at Vaccine Skeptics, Overwhelmingly Backed by FDA Panel

This resource outlines recommendations made to the United States Food and Drug Administration’s regarding the emergency use authorization of Novavax Inc’s COVID-19 vaccine. It describes the timeline of vaccine approval and distribution, and how it has been described as a possible solution to alleviate vaccine hesitancy in some.

Related Topics


This topic is coming soon!